We have performed voltage dependent imaging and spatially resolved spectroscopy on the (110) surface of Te doped GaAs single crystals with a low temperature scanning tunneling microscope (STM). A large fraction of the observed defects are identified as Te dopant atoms which can be observed down to the fifth subsurface layer. For negative sample voltages, the dopant atoms are surrounded by Friedel charge density oscillations. Spatially resolved spectroscopy above the dopant atoms and above defect free areas of the GaAs (110) surface reveals the presence of conductance peaks inside the semiconductor band gap. The appearance of the peaks can be linked to charges residing on states which are localized within the tunnel junction area. We show that these localized states can be present on the doped GaAs surface as well as at the STM tip apex.
͑Submitted 30 October 1997͒ Zh. É ksp. Teor. Fiz. 114, 359-378 ͑July 1998͒The paper considers the effect of a magnetic field B on the transport of neutral composite particles, namely excitons, in weakly disordered two-dimensional ͑2D͒ systems. In the case of classical transport ͑when the interference of different paths is neglected͒, the magnetic field suppresses exciton transport, and the static diffusion constant D(B) monotonically drops with B. When quantum-mechanical corrections due to weak localization are taken into account, D(B) becomes a nonmonotonic function of B. In weak magnetic fields, where the magnetic length is much larger than the exciton Bohr radius, l B ϭ(បc/eB) 1/2 ӷa B ϭប 2 /e 2 , a positive magnetodiffusion effect is predicted, i.e., the exciton mobility should increase with B.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.